26 pending office actions • 7 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 18981139 | Targeted Protease Compositions and Uses Related Thereto | Emory University | FERNANDEZ, SUSAN EMILY | 1651 | Non-Final OA | Dec 13, 2024 |
| 18702797 | Selective Backpropagation Through Time | The University of North Carolina at Chapel Hill | CHANG, DANIEL CHEOLJIN | 2669 | Non-Final OA | Apr 18, 2024 |
| 18688313 | Digital Sutures | Georgia Tech Research Corporation | SHOULDERS, ANNIE LEE | 3794 | Non-Final OA | Feb 29, 2024 |
| 18685765 | Uses of Propranolol for Managing Viral Infections | Leiden University Medical Center | CHONG, YONG SOO | 1623 | Non-Final OA | Feb 22, 2024 |
| 18531138 | Systems, Devices and Methods for Noninvasively Determining Jugular Venous Pressure and/or Associated Metrics | Emory University | OGLES, MATTHEW ERIC | 3791 | Non-Final OA | Dec 06, 2023 |
| 18562911 | NOVEL UNIVERSAL ANTI-RNA VIRUS AGENTS | Emory University | OLSON, ANDREA STEFFEL | 1693 | Non-Final OA | Nov 21, 2023 |
| 18288503 | Handheld Auscultation Systems, Devices, and Methods | Emory University | GHAND, JENNIFER LEIGH-STEWAR | 3796 | Non-Final OA | Oct 26, 2023 |
| 18287632 | Quinazoline Derivatives, Pharmaceutical Compositions, and Therapeutic Uses Related to Nox Inhibition | The Medical College of Wisconsin, Inc. | BELL, SARA ELIZABETH | 1625 | Non-Final OA | Oct 19, 2023 |
| 18286163 | MODIFIED NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS FOR CORONA AND OTHER VIRUSES | Emory University | GALSTER, SAMUEL LEONARD | 1693 | Non-Final OA | Oct 09, 2023 |
| 18285778 | NUCLEOSIDES AND NUCLEOTIDES ANALOGS AS ANTIVIRAL AGENTS | Emory University | LEWIS, PATRICK T | 1691 | Non-Final OA | Oct 05, 2023 |
| 18285789 | THIONUCLEOSIDES AS ANTIVIRAL AGENTS | Emory University | LAU, JONATHAN S | 1693 | Non-Final OA | Oct 05, 2023 |
| 18284236 | Managing the Acute and Long-Term Effects of Coronaviral Infections and Compositions Related Thereto | Children'S Healthcare Of Atlanta, Inc. | AULAKH, CHARANJIT | 1621 | Non-Final OA | Sep 26, 2023 |
| 18282409 | SARS-CoV-2 Antibodies and Fragments, Therapeutic Uses, Diagnostic Uses, and Compositions Related Thereto | Children'S Healthcare Of Atlanta, Inc. | FONTAINHAS, AURORA M | 1675 | Non-Final OA | Sep 15, 2023 |
| 18279726 | Scaffolds For Inducing Antibody Responses Against Antigenic Sites | Emory University | OLISS, BRENDAN PATRICK NOON | 1658 | Non-Final OA | Aug 31, 2023 |
| 18276736 | Diruthenium Catalyst Compositions and Synthetic Processes Related Thereto | Emory University | BAKSHI, PANCHAM | 1623 | Non-Final OA | Aug 10, 2023 |
| 18273973 | Methods, Devices and Systems for Generating a Chemical Gradient | Children'S Healthcare Of Atlanta, Inc. | LYLE, SOPHIA YUAN | 1796 | Non-Final OA | Jul 24, 2023 |
| 18271364 | Interleukin-37, Chimeric Antigen Receptors, Nucleic Acids, and Vectors Encoding the Same and Uses in Cancer Therapies | Children'S Healthcare Of Atlanta, Inc. | STEIN, LEAH ELIZABETH | 1641 | Non-Final OA | Jul 07, 2023 |
| 18035484 | Composite Materials for Uses in Cardiac and Other Tissue Repair | Emory University | CHEN, VIVIAN | 1787 | Non-Final OA | May 04, 2023 |
| 18030491 | Methods of Managing Side Effects of a Vasopressin Receptor Antagonist Therapy | Emory University | WEDDINGTON, KEVIN E | 1629 | Non-Final OA | Apr 05, 2023 |
| 18111350 | RESPONSE-GUIDED HCV THERAPY | Emory University | CHANDRAKUMAR, NIZAL S | 1625 | Non-Final OA | Feb 17, 2023 |
| 18041785 | 5'-SUBSTITUTED NUCLEOSIDE MONOPHOSPHATES, PRODRUGS THEREOF, AND USES RELATED THERETO | Emory University | LEE, HOI YAN NMN | 1693 | Non-Final OA | Feb 15, 2023 |
| 17909844 | Heteromultivalent Spherical Nucleic Acids and Uses in Therapeutic and Diagnostic Applications | Emory University | CROW, ROBERT THOMAS | 1683 | Non-Final OA | Sep 07, 2022 |
| 17908766 | Radionuclide Tracers of 1-Amino-3,4-Difluorocyclopentane-1-Carboxylic Acid, Derivatives, and Uses Thereof | Emory University | WESTERBERG, NISSA M | 1618 | Final Rejection | Sep 01, 2022 |
| 17908465 | Methods of Treating Cancer Using Checkpoint Inhibitors in Combination with Purine Cleaving Enzymes | Children'S Healthcare Of Atlanta, Inc. | BOECKELMAN, JACOB A | 1655 | Final Rejection | Aug 31, 2022 |
| 17639318 | Use of Deoxycholic Acid, Derivatives, or Salts Thereof in Managing Bacterial Infections and Compositions Related Thereto | Emory University | HIRAKIS, SOPHIA P | 1623 | Non-Final OA | Feb 28, 2022 |
| 16972800 | Compositions of Transforming Growth Factor-Beta Type III Receptor and Uses for Ossification | Emory University | REYNOLDS, FRED H | 1658 | Final Rejection | Dec 07, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial